| __timestamp | Bio-Techne Corporation | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 68205000 |
| Thursday, January 1, 2015 | 40853000 | 54218000 |
| Friday, January 1, 2016 | 45187000 | 15934000 |
| Sunday, January 1, 2017 | 53514000 | 24390000 |
| Monday, January 1, 2018 | 55329000 | 25389000 |
| Tuesday, January 1, 2019 | 62413000 | 72324000 |
| Wednesday, January 1, 2020 | 65192000 | 184809000 |
| Friday, January 1, 2021 | 70603000 | 205164000 |
| Saturday, January 1, 2022 | 87140000 | 245441000 |
| Sunday, January 1, 2023 | 92493000 | 271823000 |
| Monday, January 1, 2024 | 96664000 |
Unlocking the unknown
In the competitive landscape of biotechnology, innovation is key. Bio-Techne Corporation and Madrigal Pharmaceuticals, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Madrigal Pharmaceuticals has consistently outpaced Bio-Techne in R&D spending, with a peak investment in 2023 that was nearly three times higher than Bio-Techne's. This trend highlights Madrigal's aggressive push towards innovation, particularly evident in their 2020-2023 surge, where their R&D expenses grew by over 200%. Meanwhile, Bio-Techne has shown steady growth, increasing their R&D budget by approximately 213% from 2014 to 2023. This data underscores the strategic priorities of these companies, with Madrigal focusing on rapid innovation and Bio-Techne maintaining a steady, sustainable growth path. Missing data for 2024 suggests ongoing developments that could further shift this dynamic.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Bio-Techne Corporation
Research and Development Investment: Viatris Inc. vs Madrigal Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Analyzing R&D Budgets: Bio-Techne Corporation vs Geron Corporation
Comparing Innovation Spending: Bio-Techne Corporation and Galapagos NV
Analyzing R&D Budgets: Bio-Techne Corporation vs Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Madrigal Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
R&D Insights: How Madrigal Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds
R&D Insights: How Madrigal Pharmaceuticals, Inc. and Travere Therapeutics, Inc. Allocate Funds
Madrigal Pharmaceuticals, Inc. or Novavax, Inc.: Who Invests More in Innovation?
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.